The GNAS-MT group presented significantly better responsiveness to bromocriptine, consistent with a previous report that GNAS-MT adenomas are associated with higher dopamine receptor 2 mRNA expression than GNAS-WT adenomas23. This evidence concerns the gene GNAS and adenoma.